RxSight, Inc. (RXST)
7.66
-0.15
(-1.92%)
USD |
NASDAQ |
Mar 06, 10:54
RxSight Free Cash Flow : -19.34M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alphatec Holdings, Inc. | -4.41M |
| Abbott Laboratories | 7.395B |
| Accuray, Inc. | -10.71M |
| Boston Scientific Corp. | 3.658B |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.116M |
| Cash from Investing (Quarterly) | -9.614M |
| Cash from Financing (Quarterly) | 1.063M |
| Free Cash Flow Per Share (Quarterly) | -0.0547 |
| Free Cash Flow to Equity (Quarterly) | -1.728M |
| Free Cash Flow to Firm (Quarterly) | -2.248M |
| Free Cash Flow Yield | -6.18% |